Helene L. Hooimeijer

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.

Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 05, 2025

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.

Journal: Frontiers in immunology

Published: December 14, 2023

A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B.

A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B.

Journal: Journal of blood medicine

Published: July 21, 2023

Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr.

Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr.

Journal: Blood advances

Published: June 29, 2022

Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study.

Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study.

Journal: Research and practice in thrombosis and haemostasis

Published: March 04, 2022

Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands.

Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 09, 2021

Age dependency of plasma vitamin B12 status markers in Dutch children and adolescents.

Age dependency of plasma vitamin B12 status markers in Dutch children and adolescents.

Journal: Pediatric research

Published: September 05, 2020

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Journal: Blood advances

Published: August 24, 2020

A boy with joint pain associated with emicizumab treatment: The importance of plasma level measurement.

A boy with joint pain associated with emicizumab treatment: The importance of plasma level measurement.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 07, 2020

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 24, 2019

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Journal: The Lancet. Haematology

Published: June 21, 2019

Feasibility of video consultations in case of acute complications in children with haemophilia.

Feasibility of video consultations in case of acute complications in children with haemophilia.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 02, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026